Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2004-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2012-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101178657-B1 |
titleOfInvention |
Amorphous Antimicrobial Composition Containing Ceftitorene Covering Chamber |
abstract |
According to the present invention, there is provided a solid dispersion composition in which an amorphous ceftitorene covering chamber can be maintained in suspension for a long time. The present invention is a solid dispersion composition comprising 0.1 mg or more of sucrose fatty acid ester based on 100 mg effective equivalent of ceftitorene coating chamber.n n n Ceftitorene coating chamber, amorphous antibiotic composition |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104586795-A |
priorityDate |
2003-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |